Africa’s pharmaceutical industry jumped to $20.8 billion in 2013, up from just $4.7 billion a decade earlier, according to a new report from McKinsey & Company.
That growth is continuing at a rapid pace and report authors Tania Holt, Mehdi Lahrichi and Jorge Santos da Silva predict the market will be worth $40 billion to $65 billion by 2020. As developed markets stagnate, the authors conclude that the continent will be a good place for pharma companies seeking new sources of growth.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze